Ken Nelson

"Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) has decided that the CPT code 0716T - the CADScor® System - shall be assigned to APC 5733 including status indicator assignment to "S" (separately payable) for calendar year 2025. The CMS ruling means standalone fixed reimbursement is now possible for the CADScor System in outpatient settings." "The Acarix CADScor is a non-invasive, radiation free diagnostic aid powered by AI to rule out Coronary Artery Disease (CAD) with 97% accuracy in less than 10 minutes. The CADScor System is CE- and FDA-cleared, covered by more than 40 patents and used on over 40,000 patients with symptomatic chest pain." https://lnkd.in/gy9dHSte American Heart Association Heart Rhythm Society #epeeps American College of Cardiology European Society of Cardiology American College of Emergency Physicians

106

6 Comments

Another good medtech strategy article. A centralized, searchable resource for global medtech regulations is a game-changer. Here are two key benefits: 1. Easier access to documents streamlines the approval process, potentially accelerating time to market for critical devices. 2. A clearer understanding of global regulations can fuel innovation in underserved markets, improving access to healthcare technologies. #MedTech #Policy #GlobalHealth https://lnkd.in/gJWTMQPb

10

A unique solution to solve a post implant challenge that can arise with endovascular aneurysm repair!

14

Tune in to the most recent episode of Funding Medtech Podcast to listen to Jeremy Langsam at Portal Innovations, LLC and Rich Mazzola at Project Medtech discuss the details (the network, investment thesis, check size, etc.) of Portal Innovations. Links to the podcast, monthly newsletter, and website are in the comments below! Follow Project Medtech on LinkedIn for more great content or visit our website #medicaldevices #startup #medtech #projectmedtech #innovation #medicaldevice #podcast #strategy

44

5 Comments

MedTech, a $500 billion industry will more than double as TechMed becomes the new market driver. Alan Cohen, head of the prolific DCVC investment group that is fueling the next generation of medical devices has identified a new segment of the medical device industry, “TechMed”. “Whereas MedTech players are primarily product companies that monetize device sales, TechMed companies are funda­men­tally software- and platform-centric.” “The economics and business-model impli­ca­tions of the TechMed movement more closely mirror the dynamics we see from dominant tech platforms and ecosystems.” Immersive medicine, the use of media as medicine, sits firmly in the TechMed space and will drive considerable job growth for those capable of wielding media to impact change to human health and behavior while generating an amazingly potent data stream. Read all of Alan’s thesis here: https://lnkd.in/gx5BMab2 See him present next at LSI’s awesome medical conference on September 19th (Day 3) at #LSIEurope24 in Sintra, Portugal.

155

31 Comments

As we continue to innovate, the need for interoperability becomes all the more important. Healthcare orgs should ensure that new AI systems seamlessly integrate with existing tech to maximize their potential. For example, companies like StationMD rely on robust tech integration to deliver remote care to underserved populations. Without this, their ability to provide critical services would be compromised, rendering their value proposition obsolete. Fostering partnerships with tech vendors helped StationMD navigate this complex landscape, ensuring that their systems function cohesively while maintaining security and compliance. The promise of AI in healthcare is unfolding, whether we hop on the bandwagon or not. Organizations that are ready to embrace that reality are likely to come out on top in a future where personalized and efficient patient care is the norm. #HealthcareInnovation #ArtificialIntelligence #AI #PatientCare #FutureOfHealthcare

7

Tune in to the most recent episode of Funding Medtech Podcast to listen to Ryan Kole at VCapital Management and Rich Mazzola at Project Medtech discuss the details (the angel network makeup, investment thesis, check size, etc.) of VCapital. Links to the podcast, monthly newsletter, and website are in the comments below! Follow Project Medtech on LinkedIn for more great content or visit our website. #medicaldevices #startup #medtech #projectmedtech #innovation #medicaldevice #podcast #strategy

18

5 Comments

There's an alarming trend happening in healthcare. PE firms are gobbling up hospitals. Here’s two things you should know: 1. Private Equity backed hospital M&A has increased significantly - In most markets, one system has >50% market share of hospital discharges - 428 hospital and health system mergers announced from 2018 to 2023 - 8% of private hospitals are PE owned, nearly tripling since 2017 - 26% of private equity-owned hospitals serve rural populations 2. Physician practice consolidation skyrocketing - Between 2019 and 2024, more than 44,000 medical practices were acquired - PE physician practice acquisitions saw a six-fold increase from 2012 to 2021 - 78% of physicians employed by hospitals, payers, PE firms, or corporations What happens when PE firms take over a hospital? Exactly what you think: - Increases in charges, charge to cost ratio, and profit margin - Decreases in operating costs, FTE staff per bed, and capital assets - Increases in patient infections, falls, and other adverse events The financialization of healthcare will continue to happen, so buckle up. When budgets are getting squeezed, you have to bring your A game and focus on ROI, efficiency, and hard cost savings to get your medtech solution adopted. How are you seeing these trends impact your business? Data: Kaufman Hall, Health Affairs, Physicians Advocacy Institute, JAMA #privateequity #healthcare #medtech #mergersandacquisitions #consolidation #physicians

49

6 Comments

Turning a promising idea into a standout product takes foresight and strategic moves. In the latest episode of Inside MedTech Innovation, JC Herz breaks down why avoiding “maximal regret” is key to driving product innovation that lasts. Check it out! https://lnkd.in/ebGPJxVD #Leadership #BusinessStrategy #Innovation

17

1 Comment

Value-based care (VBC) represents a significant shift in healthcare, focusing on outcomes rather than procedures. Ultrasound technology is instrumental in this transition, offering high-quality diagnostics while controlling costs. Here’s what providers need to know: • The VBC approach prioritizes patient outcomes and cost efficiency. • Ultrasound in VBC is essential for accurate, timely, and cost-effective diagnostics. • Acertara's R&D is advancing ultrasound technology and enhancing patient care. • Our partnership and collaboration with healthcare providers, leaders, and institutions drive new innovations. • Ultrasound is critical to effective, efficient, and progressive healthcare delivery. At Acertara, we’re focused on integrating ultrasound solutions into the VBC framework, aiming to improve patient outcomes and contribute to the sustainable future of healthcare. #Ultrasound #ValueBasedCare #HealthEquity Partner with Acertara for ultrasound-powered value-based care. Visit https://bit.ly/3RfNOtp

21

3 Comments

The Decline of Attendance at Major Orthopedic Conferences: Analyzing the Trends https://lnkd.in/ggMMN-KJ #DigitalTechnology #healthcare #IndustryTrends #MedicalConferences #MedicalEducation #networking #orthopedics #orthopaedics #SurgicalTraining #VirtualLearning #MedicalDevices

21

9 Comments

On October 10th I'm diving deeper into what makes MedTech startup projects unique and difficult to manage with traditional methodology, as well as sharing my tips for avoiding the most common pitfalls in MedTech product development.

30

Apple pushes into sleep apnea detection but health care integration remains unclear From StatNews The article discusses the new Apple Watch sleep apnea feature to receive alerts.  This feature should be cleared by the FDA in the near future, per the Article.  The article looks at this new feature can potentially help break through as a new tool instead of the unacceptable status quo of the gold standard approach for sleep apnea screening, diagnosis, and treatment which are done at lower rates then this new tool would be able to do.  Now the question is will this new tool provide too much information, will this overload a stressed out medical system even more, or the anxiety on those with over-diagnosed information. What are your thoughts about this article? Join the conversation below 👇   https://lnkd.in/g8fd7tnv #MedicalDevices #60601 #IEC60601 #Regulatory #RegulatoryAffairs #QualityAssurance  

10

✨ Exciting updates from Singular Health Group Ltd (ASX: SHG)! Last week, we signed a Memorandum of Understanding (#MoU) with Provider Network Solutions, LLC (#PNS), a Miami-based Managed Service Organisation (#MSO) that oversees the health of more than 3.7 million members in the US. This collaboration marks a significant step in tackling a critical healthcare challenge: the lack of #interoperability that leads to duplicate medical imaging exams. This issue not only costs the US healthcare system $30 billion annually but also causes patients unnecessary discomfort and delays in diagnosis and treatment. I had the pleasure of sitting down with Fraser Palamara from Stockhead to discuss the details of this exciting project and the role played by the 3Dicom - Medical Imaging Software, as well as the cornerstone investments driving its delivery. 👉 Catch the interview here: https://lnkd.in/gs3-rTgh. Let me know your thoughts, and feel free to connect if you would like to explore the innovative work we are driving forward! 🚀 #HealthcareInnovation #MedicalImaging #Interoperability #3Dicom #ASX #Milestones

22

1 Comment

HOUSTON, TEXAS IS HOT in the MedTech ecosystem and in 17 Days there will be COLD DRINKS at the Goodwin & Lifeblood MedTech Startup Event for entrepreneurs and investors on Thursday, June 6th. 100 attendees in total and 29 spots left to register: https://shorturl.at/d1x6d Register now for this event for MedTech entrepreneurs and investors on Thursday, June 6th where there is a focal panel titled "The MedTech Startup Equation" followed by drinks and food to bring the Houston MedTech Startup community together! How to get there... 1) Register at this link https://shorturl.at/d1x6d ...or 2) Reach out to Yulia Yurevich at [email protected] ...or 3) Scan the QR code Panel description: Beyond technology, a startup needs capital, people, and partners to accomplish milestones. This panel of entrepreneurs, investors, and industry partners share their perspectives on the process and importance of identifying and leveraging these fundamentals to build companies. Fundraising, assembling management teams, and how to select credible partners for startups was the focus of this discussion. Moderator: Giovanni Lauricella, Lifeblood Panelists: 1. Investor: Mark Winters, Baylor Angel Network 2. Investor: Samia Ahsan, Houston Angel Network 3. Investor: Marcus Nelson, TMC Venture Fund 4: Entrepreneur: Tushar Sharma, Vivifi Medical 5: Entrepreneur: 🦸‍♀️ Swarna Balasubramaniam, MD, Noleus Technologies 6: Entrepreneur: Bret Boudousquie, Stratus Medical 7: Industry Partner: Kristin (Iadarola) Havranek, Goodwin 8: Industry Partner: Chelsea Isaac, Proxima CRO 9: Industry Partner: Alex Condon, Galen Data Example questions: * What is the challenge of shifting from angel investors and family offices to venture capitalist when raising capital? * What are your thoughts on saving time versus money when choosing to use or select industry partners? * How should investors support their companies beyond a check? Good money, bad money, neutral money. * How does having operating experience make you a better investor to support startups to hit milestones? * How can lawyers engage with startups early to set them up successfully when costs are a focal point, yet not having correct legal counsel early on can have long term consequences? * What is your philosophy with building companies and raising capital when it comes to “starting with the end in mind?” * Once you close financings, what is your focus on putting that capital to work in order to hit the milestones that you promised your investors? * Price vs. Value: What happens when startups cut corners or are hyper price sensitive where it leads to “you get what you pay for?” A huge shout out to Goodwin for hosting this Houston MedTech Startup Networking Event at Levit Green! With love for the growth of Houston's MedTech Ecosystem, Mister MedTech of Lifeblood The MedTech Industry's Global Recruitment & Advisory Firm www.lifeblood.com

74

3 Comments

👩🏻‍⚕️🌎Big tech still eyeing the future of AI in #healthcare. This week at the HLTH Inc. conference in Las Vegas, top executives from the global tech leaders including Google, Microsoft, Amazon, and NVIDIA unveiled their latest AI-driven solutions for the future of healthcare. Even with how rapidly the advancements in AI/ML #research, quantum computing, as well as supporting #technology and #infrastructure, headwinds still remain on how each organization will find success introducing their AI solutions into the global healthcare markets. With promises to transform areas such as documentation efficiency and operating room scheduling, these leaders emphasize a shift from single-point tools to customizable platforms designed to meet the unique needs of health systems. “Any evaluation that we do at the foundation model level is only a first draft. It does need to be pioneered by healthcare systems that are willing and able to do the research on the ground, and not every health system can do that.” - Greg Corrado, Google Research Sr. Director and Co-Founder of Google Brain Team #medicalinnovation #aihealthcare #machinelearning #quantumcomputing The Mullings Group

6

🔬💬 Let's Hear Your Voice! The FTC's proposed final non-compete rule is generating buzz in MedTech. Share your thoughts from different perspectives. Your insights shape the conversation. #MedTechTalks #DiverseViews Join the discussion here: [FTC Fact Sheet on Proposed Final Non-Compete Rule](https://lnkd.in/g8NGhBkR)

27

3 Comments

For the current class of large strategics. Technology creates new opportunities in healthcare. It is up to us to decide which to use and how to incorporate. During this unprecedented digital transition in medtech, from a financial model as well as a technological expertise perspective, structured deals / build to buys will be one of the critical pathways to success. The majority of the current strategics are not natively designed to drive technologies in surgical robotics, image guided therapies, and AI driven diagnostic and intraoperative advisement platforms. By design, the current construct of multi-billion dollar organizations in medtech have a centralized power base that is appropriately designed to hit quarterly numbers and meet the economic expectations of the financial markets, navigate a strict FDA landscape, while still serving patients. The centralized decision making from HQ of the past served the system well. In an analog medtech world, the unconnected medical device world determined the corporate SOP’s and technology development cycles up until today. In the rapidly emerging connected world of techmed, that centralized structural organization tends to resist rapid change in defense of what got us here and quarterly numbers to meet shareholder value. There is a pressure in the Executive ranks that requires new solutions, new voices, and acceptance of the challenges and threats that are eroding market positions as these digitally driven demands pick up speed. The large strategics can no longer expect to be the exclusive producer of products that the markets want to buy. They also cannot likely count on the legacy M&A model as it becomes too expensive, has proven to be unprofitable, requires too long of a development cycle and integration challenges, and most importantly does not bring the future core competencies required to keep topgrading these digitally connected solutions if the tribal knowledge is not embedded in the organization. Some of the strategics are copying the competition, which by design always has you behind. And second place in digital is not like second place in a catheter, it is usually fatal to be a #2 player in a digital / data competition. We will see a new wave of investment vehicles, lean subject matter design organizations, and economic models that provide a longer tail to drive retention and ongoing development of digitally connected platforms that will be off-balance sheet expansions of the strategics. A new medtech ecosystem is in its early days.

94

26 Comments